Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...

Many adults with diabetes and the associated complication of peripheral neuropathy, which can be painful as well as harmful, are often prescribed drugs at ... areas. A new review paper co-authored ...

State University of Buffalo (New York), and Cyclerion Therapeutics, has identified a promising approach for treating hereditary peripheral neuropathies, specifically Charcot Marie Tooth disease ...

Some diseases producing liver dysfunction can independently cause peripheral neuropathy. Hence, a cause and effect relationship between liver disease and neuropathy has been questioned.

The new findings show that ADCs, just like chemotherapy ... contributing to chemotherapy-induced peripheral neuropathy. ADCs, ...